Actively Recruiting
Biomarkers in Infection
Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-15
4200
Participants Needed
2
Research Sites
1339 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
CONDITIONS
Official Title
Biomarkers in Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Confirmed or suspected infection (for infected subjects)
- Age 18 years or older (for control subjects)
- Non-infectious clinical presentation (for control subjects)
- Normal white blood cell count (greater than 4,000 and less than 12,000) (for control subjects)
- Body temperature between 96.5 and 100.4 degrees Fahrenheit (for control subjects)
- No symptoms of productive cough, fever, painful urination, or rash (for control subjects)
- No evidence of acute coronary syndrome (for control subjects)
You will not qualify if you...
- Suspected infection (for control subjects)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Active, Not Recruiting
2
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
N
Nathan Shapiro, MD MPH
CONTACT
C
Carlo Ottanelli, BSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here